Types and Rates of Major Adverse Cardiovascular Events in Antithrombotic Trials: A Systematic Review and Meta-Analysis

Major adverse cardiovascular events (MACE) are common composite end points in trials of antithrombotic therapies, yet their definitions and component event rates may vary between cardiovascular disease and stroke populations. We compared definitions and annualized rates of MACE components, bleeding...

Celý popis

Podrobná bibliografie

Vydáno v:	Canadian journal of cardiology
Hlavní autoři:	Wang, Yundi, Fuerte-Hortigon, Alejandro, Chetty, Sarvani, Garah, Mays, Sarmiento, Robert, Barber, Philip A., Saposnik, Gustavo, Lee, Douglas S., Singnurkar, Amit, Swartz, Richard H., Varickanickal, Joann, Field, Thalia S.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Elsevier Inc 25.10.2025
Témata:	antithrombotics Cardiovascular major adverse cardiovascular events prevention stroke major adverse cardiovascular events cardiovascular stroke prevention antithrombotics
ISSN:	0828-282X, 1916-7075, 1916-7075
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!